TRCT
RVLP

Tower Research Capital (TRC)’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Tower Research Capital (TRC)’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-32,898
Closed -$2.86K – 6373
2023
Q3 		$2.86K Buy
32,898
+28,118
+588% +$8.1K ﹤0.01% 5092
2023
Q2 		$2.68K Buy
4,780
+2,135
+81% +$1.88K ﹤0.01% 5169
2023
Q1 		$3K Buy
+2,645
New +$3.17K ﹤0.01% 5284
2022
Q4 		– Sell
-15,483
Closed -$32K – 6624
2022
Q3 		$32K Buy
+15,483
New +$30.1K ﹤0.01% 3568
2022
Q2 		– Sell
-3,022
Closed -$5K – 6762
2022
Q1 		$5K Buy
3,022
+1,337
+79% +$1.91K ﹤0.01% 5142
2021
Q4 		$2K Sell
1,685
-6,163
-79% -$10K ﹤0.01% 5714
2021
Q3 		$23K Buy
7,848
+1,086
+16% +$3.65K ﹤0.01% 3613
2021
Q2 		$20K Sell
6,762
-9,354
-58% -$28.6K ﹤0.01% 3907
2021
Q1 		$53K Buy
16,116
+12,233
+315% +$50.3K ﹤0.01% 3079
2020
Q4 		$16K Sell
3,883
-2,718
-41% -$15.7K ﹤0.01% 4023
2020
Q3 		$36K Buy
6,601
+1,638
+33% +$9.43K ﹤0.01% 3670
2020
Q2 		$33K Buy
4,963
+4,746
+2,187% +$23.2K ﹤0.01% 3391
2020
Q1 		$0 Sell
217
-11,001
-98% -$58.6K ﹤0.01% 4143
2019
Q4 		$79K Buy
11,218
+1,764
+19% +$9.41K 0.01% 1080
2019
Q3 		$36K Buy
9,454
+8,829
+1,413% +$29.9K ﹤0.01% 2033
2019
Q2 		$2K Sell
625
-3,392
-84% -$11.3K ﹤0.01% 3345
2019
Q1 		$14K Buy
4,017
+1,890
+89% +$13.9K ﹤0.01% 2492
2018
Q4 		$16K Buy
+2,127
New +$17K ﹤0.01% 2137

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Tower Research Capital (TRC)'s RVLP Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 32,898 shares — an estimated $2.86K sold.

Tower Research Capital (TRC) first reported a position in RVLP in Q4 2018 and held it in 18 quarters. The position peaked at $79K in Q4 2019. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 32,898 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $2.86K.
  • Tower Research Capital (TRC) first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 18 quarters.
  • Tower Research Capital (TRC)'s RVL Pharmaceuticals plc Ordinary Shares position peaked at $79K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.